ARCHIVES

Celebrex Studies Show Polyp Reduction, Point To Challenges In Biomarker Validation

This article is from The Cancer Letter archive.

Vol. 29 No. 4 | April 28, 2006

Download PDF Visit The Full Archive

Related Articles

NCI Backed Studies Indicate Overweight Not Much Of a Cancer Risk Factor

June 19, 1987

Consructio Needs Over Next Five Years Total Estimated $696 Million; NCI Share-$132 Million

January 19, 1979

Health Care Delivery: Value Of Informatics To PPMs Is a Message for Academic Centers

November 22, 1996

President Accepts Rauscher Resignation

October 1, 1976

In Brief: Painter Is AMA President-Elect; FDA Approves Taxol; Protocol Enrolls 150-200 A Month

August 14, 1992

OCEANS Study: Avastin Shows Tumor Shrinkage in 79 Percent

June 24, 2011